-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out today.
  • Burning Rock Biotech (NASDAQ:BNR) stock moved upwards by 19.45% to $14.8. The market value of their outstanding shares is at $130.6 million.
  • Skye Bioscience (NASDAQ:SKYE) shares moved upwards by 16.42% to $0.8. The market value of their outstanding shares is at $3.0 million.
  • Eikon Therapeutics (NASDAQ:EIKN) shares moved upwards by 15.84% to $6.8. The market value of their outstanding shares is at $317.9 million.
  • Harrow (NASDAQ:HROW) stock rose 15.61% to $31.76. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out yesterday.
  • Senseonics Holdings (NASDAQ:SENS) stock increased by 13.26% to $11.1. The market value of their outstanding shares is at $518.1 million. As per the news, the Q3 earnings report came out yesterday.

Losers

  • Karyopharm Therapeutics (NASDAQ:KPTI) stock decreased by 18.8% to $0.03 during Tuesday's pre-market session.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares declined by 12.86% to $2.17. The company's market cap stands at $2.7 million.
  • GeneDx Holdings (NASDAQ:WGS) shares fell 11.75% to $58.0. The company's market cap stands at $1.9 billion. As per the news, the Q3 earnings report came out yesterday.
  • Nordicus Partners (NASDAQ:NORD) stock fell 11.65% to $3.11. The company's market cap stands at $68.4 million.
  • Lakewood-Amedex (NASDAQ:LABT) stock decreased by 10.96% to $0.37.
  • Jade Biosciences (NASDAQ:JBIO) stock declined by 9.62% to $14.1. The company's market cap stands at $992.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending